Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1981 Apr;45(4):447–456. doi: 10.1136/hrt.45.4.447

Systolic time intervals and haemodynamic changes during intravenous infusion of prostaglandins F2 alpha and E2.

P Thayssen, N J Secher, P Arnsbo
PMCID: PMC482547  PMID: 7225258

Full text

PDF
447

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen L. H., Secher N. J. Pattern of total and regional lung function in subjects with bronchoconstriction induced by 15-me PGF2 alpha. Thorax. 1976 Dec;31(6):685–692. doi: 10.1136/thx.31.6.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergström S., Carlson L. A., Weeks J. R. The prostaglandins: a family of biologically active lipids. Pharmacol Rev. 1968 Mar;20(1):1–48. [PubMed] [Google Scholar]
  3. Brown R., Ingram R. H., Jr, McFadden E. R., Jr Effects of prostaglandin F2alpha on lung mechanics in nonasthmatic and asthmatic subjects. J Appl Physiol Respir Environ Exerc Physiol. 1978 Feb;44(2):150–155. doi: 10.1152/jappl.1978.44.2.150. [DOI] [PubMed] [Google Scholar]
  4. Carlson L. A., Ekelund L. G., Orö L. Clinical, metabolic and cardiovascular effects of different prostaglandins in man. Acta Med Scand. 1970 Dec;188(6):553–559. doi: 10.1111/j.0954-6820.1970.tb08082.x. [DOI] [PubMed] [Google Scholar]
  5. Eriksen S., Hommelgaard P., Frost N., Wernberg M., Johannsen G. Barbiturater og systoliske tidsintervaller. En sammenligning mellem den umiddelbare virkning af tiopental og metoheksital. Ugeskr Laeger. 1980 Mar 31;142(14):890–891. [PubMed] [Google Scholar]
  6. Flerov E. V., Ismailov Sh I. Vliianie prostaglandina F2alpha na sistemnuiu i regionarnuiu gemodinamiku sobak. Farmakol Toksikol. 1977 Jan-Feb;40(1):44–50. [PubMed] [Google Scholar]
  7. Hyman A. L., Mathe A. A., Leslie C. A., Matthews C. C., Bennett J. T., Spannhake E. W., Kadowitz P. J. Modification of pulmonary vascular responses to arachidonic acid by alterations in physiologic state. J Pharmacol Exp Ther. 1978 Nov;207(2):388–401. [PubMed] [Google Scholar]
  8. Kadowitz P. J., Joiner P. D., Hyman A. L. Effect of prostaglandin E2 on pulmonary vascular resistance in intact dog, swine and lamb. Eur J Pharmacol. 1975 Mar;31(1):72–80. doi: 10.1016/0014-2999(75)90080-1. [DOI] [PubMed] [Google Scholar]
  9. Lonigro A. J., Dawson C. A. Vascular responses to prostaglandin F 2 alpha in isolated cat lungs. Circ Res. 1975 Jun;36(6):706–712. doi: 10.1161/01.res.36.6.706. [DOI] [PubMed] [Google Scholar]
  10. McGiff J. C., Terragno N. A., Strand J. C., Lee J. B., Lonigro A. J., Ng K. K. Selective passage of prostaglandins across the lung. Nature. 1969 Aug 16;223(5207):742–745. doi: 10.1038/223742b0. [DOI] [PubMed] [Google Scholar]
  11. Piper P. J., Vane J. R., Wyllie J. H. Inactivation of prostaglandins by the lungs. Nature. 1970 Feb 14;225(5233):600–604. doi: 10.1038/225600a0. [DOI] [PubMed] [Google Scholar]
  12. Retzke U., Schwarz R. Herz-Kreislaufwirkungen von Prostaglandin F2alpha in der Frühschwangerschaft. Zentralbl Gynakol. 1976;98(22):1356–1361. [PubMed] [Google Scholar]
  13. Schrör K., Berg-Becker M., Nookhwun C. The specificity of prostaglandin E2 (PGE2) in reducing coronary vascular resistance: A comparison with adenosine. Basic Res Cardiol. 1978 May-Jun;73(3):287–297. doi: 10.1007/BF01906734. [DOI] [PubMed] [Google Scholar]
  14. Schwarz R., Retzke U. Die kardiovaskuläre Wirkung von Prostaglandin E2 in der Frühschwangerschaft. Zentralbl Gynakol. 1976;98(22):1362–1367. [PubMed] [Google Scholar]
  15. Secher N. J., Andersen L. H. Changes in the pattern of regional pulmonary blood flow after PGF2alpha infusion in pregnant women. Cardiovasc Res. 1977 Jan;11(1):26–30. doi: 10.1093/cvr/11.1.26. [DOI] [PubMed] [Google Scholar]
  16. Shaver J. A., Kroetz F. W., Leonard J. J., Paley H. W. The effect of steady-state increases in systemic arterial pressure on the duration of left ventricular ejection time. J Clin Invest. 1968 Jan;47(1):217–230. doi: 10.1172/JCI105711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Shimizu T., Taira N. Vasodilatation by prostaglandin F2alpha in the canine tongue through a parasympathetic mechanism. Br J Pharmacol. 1978 Jul;63(3):567–574. doi: 10.1111/j.1476-5381.1978.tb07813.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sonntag H., Hellberg K., Schenk H. D., Donath U., Regensburger D., Kettler D., Duchanova H., Larsen R. Effects of thiopental (Trapanal) on coronary blood flow and myocardial metabolism in man. Acta Anaesthesiol Scand. 1975;19(1):69–78. doi: 10.1111/j.1399-6576.1975.tb05224.x. [DOI] [PubMed] [Google Scholar]
  19. WEISSLER A. M., PEELER R. G., ROEHLL W. H., Jr Relationships between left ventricular ejection time, stroke volume, and heart rate in normal individuals and patients with cardiovascular disease. Am Heart J. 1961 Sep;62:367–378. doi: 10.1016/0002-8703(61)90403-3. [DOI] [PubMed] [Google Scholar]
  20. Weissler A. M., Harris W. S., Schoenfeld C. D. Systolic time intervals in heart failure in man. Circulation. 1968 Feb;37(2):149–159. doi: 10.1161/01.cir.37.2.149. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES